Genmab | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Amarin USD 3K 3K 2024-12
Amgen USD 694M 29M 2025-06
argenx SE 1.13M 9K 2025-06
AstraZeneca 303M 126M 2025-06
Bayer 495M 89M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Demant 435M 27M 2025-06
Exelixis 23.4M 3.9M 2023-09
Fresenius Medical Care EUR 96.58M 15.58M 2025-06
Galapagos EUR 780K 49.34M 2025-03
Genmab DKK 9M 4M 2025-06
GlaxoSmithKline 184M 22M 2025-06
GN Store Nord 297M 69M 2025-06
GRIFOLS EUR 202.71M 94.07M 2024-06
Hikma Pharmaceutical 22M 9M 2024-06
Insmed USD 21.24M 1.5M 2025-06
Lonza CHF 70M 11M 2024-12
Merck 79M 1000K 2025-06
Novartis USD 289M 19M 2025-06
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 148M 65M 2025-06
UCB 108M 16M 2024-12


Genmab Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.